FUL Beats Earnings but Revenue Falls Again

H.B. Fuller (FUL) reported fiscal 2025 Q4 earnings on Jan 22, 2026, with non-GAAP EPS of $1.28, exceeding estimates by 4.07%, while revenue fell to $894.8M (down 3.1% YoY). The company guided to 2026 adjusted EBITDA of $630M–$660M, in line with prior expectations, and maintained dividend consistency with a $0.235/share payout.

Revenue

The Engineering Adhesives segment led with $320M revenue, supported by strategic acquisitions in medical and fastener technologies, while Construction Adhesives contributed $280M despite broader market challenges. Hygiene and Health segments totaled $294.8M, reflecting volume pressures.

Earnings/Net Income

H.B. Fuller returned to profitability with net income of $29.73M (19.0% EBITDA margin), a 510% improvement from a $7.25M loss in Q4 2024. This marked 20+ years of consistent quarterly profitability, underscoring operational resilience. The EPS turnaround of 507.7% highlights effective cost management and margin expansion.

Post-Earnings Price Action Review

A backtest of buying FUL on revenue beats and holding 30 days from 2021–2026 underperformed the benchmark, with a 22.70% return versus 77.56% for the market. The strategy’s -54.86% excess return, 0.15 Sharpe Ratio, and 43.32% max drawdown indicate poor risk-adjusted performance. Recent Q4 2025 results showed EPS strength but revenue misses (-3.1% YoY), leading to a 1.42% premarket decline. Margins improved via 14.6% higher adjusted EBITDA and 25% stronger cash flow, yet organic volume declines persist.

CEO Commentary

CEO Celeste Mastin emphasized “strong momentum” in Q4, crediting cost discipline and M&A as an “EBITDA compounder.” The “Quantum Leap” initiative aims to accelerate growth through innovation and geographic expansion, with 2026 guidance reflecting cautious optimism amid volume headwinds.

Guidance

The company expects 2026 revenue to grow 0–2%, with adjusted EBITDA of $630M–$660M and EPS of $4.35–$4.70. Strategic priorities include margin expansion, organic innovation, and disciplined M&A.

Additional News

1. Dividend Consistency: FUL declared a $0.235/share quarterly dividend, maintaining 58 consecutive years of payouts, with a forward yield of 1.56%.

2. M&A Activity: Acquisitions in medical adhesives and fastener technology bolstered Engineering Adhesives’ growth.

3. Strategic Initiatives: The “Quantum Leap” plan targets long-term margin expansion and global footprint enhancement.

Final Analysis

FUL’s Q4 results highlight a resilient margin structure despite revenue declines, supported by disciplined cost controls. While the stock faces near-term volatility, its 20-year profitability streak and dividend consistency appeal to income-focused investors. Analysts remain cautiously optimistic, with price targets ranging from $60–$84, reflecting confidence in long-term margin expansion.